BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 36822479)

  • 1. Ketohexokinase-C regulates global protein acetylation to decrease carnitine palmitoyltransferase 1a-mediated fatty acid oxidation.
    Helsley RN; Park SH; Vekaria HJ; Sullivan PG; Conroy LR; Sun RC; Romero MDM; Herrero L; Bons J; King CD; Rose J; Meyer JG; Schilling B; Kahn CR; Softic S
    J Hepatol; 2023 Jul; 79(1):25-42. PubMed ID: 36822479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fructose induced KHK-C can increase ER stress independent of its effect on lipogenesis to drive liver disease in diet-induced and genetic models of NAFLD.
    Park SH; Helsley RN; Fadhul T; Willoughby JLS; Noetzli L; Tu HC; Solheim MH; Fujisaka S; Pan H; Dreyfuss JM; Bons J; Rose J; King CD; Schilling B; Lusis AJ; Pan C; Gupta M; Kulkarni RN; Fitzgerald K; Kern PA; Divanovic S; Kahn CR; Softic S
    Metabolism; 2023 Aug; 145():155591. PubMed ID: 37230214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary Sugars Alter Hepatic Fatty Acid Oxidation via Transcriptional and Post-translational Modifications of Mitochondrial Proteins.
    Softic S; Meyer JG; Wang GX; Gupta MK; Batista TM; Lauritzen HPMM; Fujisaka S; Serra D; Herrero L; Willoughby J; Fitzgerald K; Ilkayeva O; Newgard CB; Gibson BW; Schilling B; Cohen DE; Kahn CR
    Cell Metab; 2019 Oct; 30(4):735-753.e4. PubMed ID: 31577934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling.
    Softic S; Gupta MK; Wang GX; Fujisaka S; O'Neill BT; Rao TN; Willoughby J; Harbison C; Fitzgerald K; Ilkayeva O; Newgard CB; Cohen DE; Kahn CR
    J Clin Invest; 2017 Nov; 127(11):4059-4074. PubMed ID: 28972537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fructose impairs fat oxidation: Implications for the mechanism of western diet-induced NAFLD.
    Inci MK; Park SH; Helsley RN; Attia SL; Softic S
    J Nutr Biochem; 2023 Apr; 114():109224. PubMed ID: 36403701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary supplementation with myo-inositol reduces hepatic triglyceride accumulation and expression of both fructolytic and lipogenic genes in rats fed a high-fructose diet.
    Shimada M; Hibino M; Takeshita A
    Nutr Res; 2017 Nov; 47():21-27. PubMed ID: 29241575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketohexokinase knockout mice, a model for essential fructosuria, exhibit altered fructose metabolism and are protected from diet-induced metabolic defects.
    Miller CO; Yang X; Lu K; Cao J; Herath K; Rosahl TW; Askew R; Pavlovic G; Zhou G; Li C; Akiyama TE
    Am J Physiol Endocrinol Metab; 2018 Sep; 315(3):E386-E393. PubMed ID: 29870677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fructose Induced KHK-C Increases ER Stress and Modulates Hepatic Transcriptome to Drive Liver Disease in Diet-Induced and Genetic Models of NAFLD.
    Park SH; Helsley RN; Fadhul T; Willoughby JLS; Noetzli L; Tu HC; Solheim MH; Fujisaka S; Pan H; Dreyfuss JM; Bons J; Rose J; King CD; Schilling B; Lusis AJ; Pan C; Gupta M; Kulkarni RN; Fitzgerald K; Kern PA; Divanovic S; Kahn CR; Softic S
    bioRxiv; 2023 Jan; ():. PubMed ID: 36747758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction.
    Gutierrez JA; Liu W; Perez S; Xing G; Sonnenberg G; Kou K; Blatnik M; Allen R; Weng Y; Vera NB; Chidsey K; Bergman A; Somayaji V; Crowley C; Clasquin MF; Nigam A; Fulham MA; Erion DM; Ross TT; Esler WP; Magee TV; Pfefferkorn JA; Bence KK; Birnbaum MJ; Tesz GJ
    Mol Metab; 2021 Jun; 48():101196. PubMed ID: 33667726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver-specific deletion of IGF2 mRNA binding protein-2/IMP2 reduces hepatic fatty acid oxidation and increases hepatic triglyceride accumulation.
    Regué L; Minichiello L; Avruch J; Dai N
    J Biol Chem; 2019 Aug; 294(31):11944-11951. PubMed ID: 31209109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-Type-Specific, Ketohexokinase-Dependent Induction by Fructose of Lipogenic Gene Expression in Mouse Small Intestine.
    Al-Jawadi A; Patel CR; Shiarella RJ; Romelus E; Auvinen M; Guardia J; Pearce SC; Kishida K; Yu S; Gao N; Ferraris RP
    J Nutr; 2020 Jul; 150(7):1722-1730. PubMed ID: 32386219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The small intestine shields the liver from fructose-induced steatosis.
    Jang C; Wada S; Yang S; Gosis B; Zeng X; Zhang Z; Shen Y; Lee G; Arany Z; Rabinowitz JD
    Nat Metab; 2020 Jul; 2(7):586-593. PubMed ID: 32694791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fructose-induced increases in expression of intestinal fructolytic and gluconeogenic genes are regulated by GLUT5 and KHK.
    Patel C; Douard V; Yu S; Tharabenjasin P; Gao N; Ferraris RP
    Am J Physiol Regul Integr Comp Physiol; 2015 Sep; 309(5):R499-509. PubMed ID: 26084694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone Growth is Influenced by Fructose in Adolescent Male Mice Lacking Ketohexokinase (KHK).
    Williams EAJ; Douard V; Sugimoto K; Inui H; Devime F; Zhang X; Kishida K; Ferraris RP; Fritton JC
    Calcif Tissue Int; 2020 May; 106(5):541-552. PubMed ID: 31996963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis.
    Shepherd EL; Saborano R; Northall E; Matsuda K; Ogino H; Yashiro H; Pickens J; Feaver RE; Cole BK; Hoang SA; Lawson MJ; Olson M; Figler RA; Reardon JE; Nishigaki N; Wamhoff BR; Günther UL; Hirschfield G; Erion DM; Lalor PF
    JHEP Rep; 2021 Apr; 3(2):100217. PubMed ID: 33490936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
    Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIF-driven SF3B1 induces KHK-C to enforce fructolysis and heart disease.
    Mirtschink P; Krishnan J; Grimm F; Sarre A; Hörl M; Kayikci M; Fankhauser N; Christinat Y; Cortijo C; Feehan O; Vukolic A; Sossalla S; Stehr SN; Ule J; Zamboni N; Pedrazzini T; Krek W
    Nature; 2015 Jun; 522(7557):444-449. PubMed ID: 26083752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fructose and hepatic insulin resistance.
    Softic S; Stanhope KL; Boucher J; Divanovic S; Lanaspa MA; Johnson RJ; Kahn CR
    Crit Rev Clin Lab Sci; 2020 Aug; 57(5):308-322. PubMed ID: 31935149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.
    Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced acetylation of ATP-citrate lyase promotes the progression of nonalcoholic fatty liver disease.
    Guo L; Guo YY; Li BY; Peng WQ; Chang XX; Gao X; Tang QQ
    J Biol Chem; 2019 Aug; 294(31):11805-11816. PubMed ID: 31197036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.